ASHG 2026 has ended. This guide stays up as the record of who was there. Next: ASHG 2027, Oct 26–30, 2027 in Nashville

University of Manitoba at ASHG 2026

Oct 20–24, 2026 Montréal, Canada ~7.5k attendees Website

University of Manitoba brings 10 presentations from 4 research groups to ASHG 2026 in Montréal. Its program centres on rare disease, population genetics and computational genomics. The Drögemöller Lab brings work on hearing loss and dementia, Wright Lab Neurogenomics Research brings long-read diagnosis for neuromuscular disorders, and Marcogliese Lab brings drug targeting of PAK1 variants.

OrganizationASHG 2026 Attendance
University of Manitoba
Winnipeg, Manitoba
4 PhD Students · 3 PIs
Drögemöller Labdrogemollerlab.com
Wet + dry lab~8 people
Generates single-cell multiomic and spatial transcriptomic data with 10x Genomics instruments and analyzes genomic datasets. Studies drug-induced and age-related hearing loss, including dementia links.
21 papers since 2024
›
Large-scale audiometric phenotyping identifies distinct genes and pathways involved in hearing loss subtypes
Communications Biology, 2025
Genetic Variations in Bitter Taste Receptors and COVID-19 in the Canadian Longitudinal Study on Aging
Biomedicines, 2025
CIAO1 and MMS19 deficiency: A lethal neurodegenerative phenotype caused by cytosolic Fe-S cluster protein assembly disorders
Genetics in Medicine, 2024
Source: OpenAlex author A5028891716
Funded by Canadian Foundation for Innovation, CIHR +2 more
›
Canada Research Chair, Tier 2 Canada Research Chair in Pharmacogenomics and Precision Medicine · 2020-current
A federal award that pays part of the chair holder's salary plus research support, five years for Tier 2 and seven for Tier 1.
“holds a Tier 2 Canada Research Chair in Pharmacogenomics and Precision Medicine”
Canadian Foundation for Innovation, John R. Evans Leaders Fund · active
“Thanks to support from the Canadian Foundation for Innovation-John R. Evans Leaders Fund”
CIHR, Project Grant · active
Canada's federal health-research funder, the equivalent of the NIH.
“Very grateful to have received a CIHR project Grant”
+1 more on the lab page
Source: lab pages
16 platforms and techniques
›
Runs
Precision Genomics Suite (PGS), Chromium iX Single-Cell Library Preparation System, CytAssist Visium System, Xenium In Situ Sequencing System, TapeStation QC Platform, QuantStudio Pro 6
Techniques
Genome-wide association studies (GWAS), Transcriptome-wide association studies (TWAS), Polygenic scores, Single-cell polygenic enrichment analyses, Multiomic data integration, Mendelian randomization, Trajectory inference, Differential abundance, CellChat, Mouse inner-ear models
Source: lab pages
Currently hiring
›
“Dr. Drögemöller is currently recruiting graduate students and postdoctoral fellows with expertise in genomics, bioinformatics, single cell technologies, and precision medicine.”
Source: lab positions page
Poster
Wed Oct 21
2:30 pm
Integrative analysis of large-scale genomic and multiomic datasets to identify otoprotectants for the prevention of cisplatin-induced ototoxicity
Collaborators: Sunnybrook Research Institute, Children's Hospital Research Institute of Manitoba +1 more
Single-cellMulti-omicsPharmacogenomicsBioinformatics
Poster
Fri Oct 23
2:30 pm
Mapping the genetic mechanisms linking age-related hearing loss to dementia
Collaborators: Medical University of South Carolina, Children’s Hospital Foundation of Manitoba +1 more
Alzheimer’s diseaseSensory disordersComplex traitsGenotype-phenotype correlations
Poster
Fri Oct 23
2:30 pm
Resolving the genomic and cellular architecture of age-related hearing loss subtypes using automated audiogram phenotyping and single-cell sequencing
Collaborators: Medical University of South Carolina
Complex traitsGenome-wide association studyLarge-scale biobanksSingle-cell
Wright Lab Neurogenomics Researchgalenwrightlab.com
Wet + dry lab~6 people
Uses genomic fine mapping, single-cell sequencing, gene editing and human stem-cell-derived neural models. Studies genetic modifiers of Huntington disease, CANVAS and Rett syndrome.
7 papers since 2024
›
Unbiased human genomic characterization of polyglutamine disorder genes to guide biological understanding and therapeutic strategies
medRxiv, 2025
Genomic characterization of Huntington’s disease genetic modifiers informs drug target tractability
Brain Communications, 2024
A multi-centre, tolerability study of a cannabidiol-enriched Cannabis Herbal Extract for chronic headaches in adolescents: The CAN-CHA protocol
PLoS ONE, 2024
Source: OpenAlex author A5077683545
Funded by Canada Foundation for Innovation, Canadian Institutes of Health Research +7 more
›
Canada Foundation for Innovation, CFI-JELF Grant (co-PI) · active
“CFI-JELF Grant (co-PI): Precision Genomics Suite. Funded by the Canada Foundation for Innovation ($1,328,074)”
Canadian Institutes of Health Research, Catalyst Grant: Analysis of CLSA Data · active
“Catalyst Grant: Analysis of CLSA Data (co-PI). Funded by the Canadian Institutes of Health Research ($70,000)”
University of Manitoba, University Research Grants Program Grant · active
“University Research Grants Program Grant: Population screening of RFC1 expansions related to an underreported ataxia”
+6 more on the lab page
Source: lab pages
9 platforms and techniques
›
Runs
Chromium iX, Visium CytAssist, Xenium Analyzer
Techniques
Genomic fine mapping, Single-cell sequencing, Machine learning, Human stem cells, Neural cell culture, CRISPR gene editing
Source: lab pages
Currently hiring
›
“We are always looking to hire trainees with an interest in neurogenomics - please get in contact with us!”
Source: lab positions page
Talk
Wed Oct 21
1:51 pm
Long-read multi-omic sequencing for genetic diagnosis of neuromuscular disorders
Collaborators: Children's Hospital Research Institute of Manitoba
NeurogeneticsLong-read sequencingRNA-seqExome/genome sequencing
Poster
Thu Oct 22
4:15 pm
★ Reviewers’ Choice
Long-read multi-omic sequencing for genetic diagnosis of neuromuscular disorders
Collaborators: Children's Hospital Research Institute of Manitoba
Exome/genome sequencingLong-read sequencingMendelian disorderNeurogenetics
Marcogliese Labmarcoglieselab.com
Wet lab~12 people
Uses Drosophila, mice, human cells and CRISPR-Cas9 to assess neurological-disease variants and model disease mechanisms. Focuses on rare neurological disorders, including NEDAMSS.
13 papers since 2024
›
Excess Wnt in neurological disease
Biochemical Journal, 2025
Cdk8/CDK19 promotes mitochondrial fission through Drp1 phosphorylation and can phenotypically suppress pink1 deficiency in Drosophila
Nature Communications, 2024
Variant functional assessment in Drosophila by overexpression: what can we learn?
Genome, 2024
Source: OpenAlex author A5002015310
Funded by Research Manitoba, Brain Canada +2 more
›
Research Manitoba · active
“We have recently garnered support from Research Manitoba, Brain Canada and AFM Telethon.”
Brain Canada · active
“We have recently garnered support from Research Manitoba, Brain Canada and AFM Telethon.”
AFM Telethon · active
“We have recently garnered support from Research Manitoba, Brain Canada and AFM Telethon.”
+1 more on the lab page
Source: lab pages
6 platforms and techniques
›
Runs
in vivo confocal microscopy
Techniques
CRISPR-Cas9 GAL4 replacement, RNAi rescue, Drosophila melanogaster models, mouse models, iPSC-derived neurons or glia
Source: lab pages
No openings posted
Poster
Wed Oct 21
2:30 pm
PAK1 variant function and drug targeting using Drosophila melanogaster
Collaborators: Dalhousie University
Genotype-phenotype correlationsIntellectual and developmental disabilityMendelian disorderModel organisms
Poster
Fri Oct 23
2:30 pm
★ Reviewers’ Choice
CK2 variant function and disease modelling in Drosophila reveal allelic heterogeneity and Wnt/β-catenin-mediated phenotypes
Collaborators: Children's Hospital Research Institute of Manitoba
Brain/nervous systemEpilepsyMendelian disorderModel organisms
Statistical Genomics and Bioinformatics Platformumanitoba.ca/health-sciences/research/statistical-genomics-and-bioinformatics
Wet + dry lab~2 people
Provides Illumina, Nanopore and 10x Genomics sequencing plus bioinformatics analysis. Serves University of Manitoba, partnering institutes, and external academic and industrial users.
25 papers since 2024
›
Doxorubicin, a DNA intercalator, inhibits transcription elongation
Biochemistry and Cell Biology, 2025
Enterococci as a One Health indicator of antimicrobial resistance
Canadian Journal of Microbiology, 2024
NERD-seq: a novel approach of Nanopore direct RNA sequencing that expands representation of non-coding RNAs
Genome biology, 2024
Source: OpenAlex author A5038643122
14 platforms and techniques
›
Works with
Short-read genome sequencing (Illumina), Long-read genome sequencing (Nanopore), Direct long-read sequencing, NERD-Seq, ChIP-Seq, RIP-Seq, 10x Genomics single-cell transcriptomics, ATAC-Seq
Techniques
GWAS and TWAS, EWAS and mQTL mapping, eQTL and sQTL mapping, Rare variant analysis, Mendelian randomization, Polygenic risk score analysis
Source: lab pages
No funding stated · No openings posted
Poster
Fri Oct 23
2:30 pm
Leveraging Nanopore Long-Read Sequencing to Resolve Undiagnosed Rare Disease Patients
Long-read sequencingMendelian disorderPrecision medicineClinical testing
1 more presenter — research group not yet identified

Explore the full ASHG 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Montréal. Leave your work email and we’ll be in touch.

Privacy

Download the full ASHG 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at University of Manitoba

Tell us what you sell and we’ll find the people at University of Manitoba most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction